ACADEMIA
Drug Damage Watchdog Calls for Halt to Easing of Safety Management Procedures for Thalidomide
The Yakugai Ombudsperson “Medwatcher Japan”(drug damage watchdog group) on June 21 submitted a petition to the Minister of Health, Labor and Welfare Yoko Komiyama calling for cautious discussions for reviewing the safety management procedures of TERMS (Thalidomide Education and Risk…
To read the full story
ACADEMIA
- Arava Safety Backup at Risk as Questran Supply Falters on Nitrosamine Issue
May 11, 2026
- NCC Launches First Japan Trial for CP Inhibitor-Related Liver Dysfunction
April 27, 2026
- Dementia Drugs See Modest Uptake in Japan amid Eligibility Limits, Safety Concerns
April 9, 2026
- Cancer Drug Supply Risks Spur Calls for Pricing Reform: JSMO
March 31, 2026
- Japan Ophthalmology Society Flags Off-Label Concerns Ahead of Upneeq Launch
March 30, 2026
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…





